Designer drugs: a brief history of the attempt to systematize on the example of «spice» and «salts» (review)
Research Article
DOI: 10.21661/r-116151
Open Access
- Published in:
- Monthly international scientific journal «Interactive science»
- Authors:
- Mrykhin V.V. 1 , Antsyborov A.V. 2
- Work direction:
- Медицина
- Rating:
- Article accesses:
- 4885
- Published in:
- doaj
- eLibrary.ru
1 FSFEI of HE “Rostov State Medical University” of Russian Ministry of Health
2 Mental Health Clinic «Psyche»
2 Mental Health Clinic «Psyche»
- APA
For citation:
Mrykhin V. V., & Antsyborov A. V. (2017). Designer drugs: a brief history of the attempt to systematize on the example of «spice» and «salts» (review). Interactive science, 36-39. https://doi.org/10.21661/r-116151
- Full text
- Metrics
UDC 61
DOI: 10.21661/r-116151
Abstract
The article reviews Russian and international literature on synthetic (designer) drugs. A special place is given to the most common designer drugs-synthetic cathinones («salts») and synthetic cannabinoids («spice»). On the basis of this literature the authors analyse the chemical structure of synthetic cathinones and synthetic cannabinoids, the psychoactive effects of these substances on the body, the ability to produce mental, somatic and neurological disorders.
Keywords
References
- 1. Головко А.И. «Новые» запрещенные каннабиноиды. Нейрохимия и нейробиология / А.И. Головко, А.Г. Софронов, Г.А. Софронов // Наркология. – 2010. – №7. – С. 68–83.
- 2. Митин А.В. Исследование курительных ароматических смесей // Судебная экспертиза. – 2010. – №1. – С. 30–39.
- 3. Головко А.И. «Токсикологическая характеристика дизайнерских наркотиков / Баринов В.А. [и др.] //Токсикология. – Т. 16. – 20 января 2015.
- 4. Менделевич В.Д. Психотические расстройства в результате употребления наркотиков: Современное состояние проблемы // Наркология. – 2014. – №7. – С. 93–100.
- 5. Moore T.H., Zammit S., Lingford-Hughes A., Barnes T.R., Jones P.B., Burke M., Lewis G. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review // Lancet. – 2007. – Vol. 370. – №9584. – P. 319–328.
- 6. Müller H., Sperling W., Köhrmann M., Huttner H.B., Kornhuber J., Maler J.M. The synthetic cannabinoid Spice as a trigger for an acute exacerbation of cannabis induced recurrent psychotic episodes // Schizophr. Res. – 2010. – Vol. 118. – №1–3. – P. 309–310.
- 7. Müller-Vahl K.R., Emrich H.M. Cannabis and schizophrenia: towards a cannabinoid hypothesis of schizophrenia // Expert Rev. Neurother. – 2008. – Vol. 8. – №7. – P. 1037–1048.
- 8. Schneir A.B., Cullen J., Ly B.T. «Spice» girls: synthetic cannabinoid intoxication // J. Emerg. Med. – 2011. – Vol. 40. – №3. – P. 296–299.
- 9. Van der Veer N., Friday J. Persistent psychosis following the use of Spice // Schizophr. Res. – 2011. – Vol. 130, №1–3. – P. 285–286.
- 10. Zimmermann U.S., Winkelmann P.R., Pilhatsch M., Nees J.A., Spanagel R., Schulz K. Withdrawal phenomena and dependence syndrome after the consumption of «spice gold» // Dtsch. Arztebl. Int. – 2009. – Vol. 106. – №27. – P. 464–467.
- 11. Winstock A.R., Mitcheson L.R., Deluca P. et al Mephedrone, new kid for the chop? – 2011. – Addiction 106(1):154–161.
- 12. Karch’s Pathology of Drug Abuse Fifth Edition 2016 by Taylor & Francis Group, LLC CRC Press is an imprint of Taylor & Francis Group, an Informa business.
Comments(0)